Product NDC: | 24208-555 |
Proprietary Name: | Bacitracin Zinc and Polymyxin B Sulfate |
Non Proprietary Name: | Bacitracin Zinc and Polymyxin B Sulfate |
Active Ingredient(s): | 500; 10000 1/g; 1/g & nbsp; Bacitracin Zinc and Polymyxin B Sulfate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24208-555 |
Labeler Name: | Bausch & Lomb Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA064046 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080425 |
Package NDC: | 24208-555-55 |
Package Description: | 1 TUBE in 1 CARTON (24208-555-55) > 3.5 g in 1 TUBE |
NDC Code | 24208-555-55 |
Proprietary Name | Bacitracin Zinc and Polymyxin B Sulfate |
Package Description | 1 TUBE in 1 CARTON (24208-555-55) > 3.5 g in 1 TUBE |
Product NDC | 24208-555 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Bacitracin Zinc and Polymyxin B Sulfate |
Dosage Form Name | OINTMENT |
Route Name | OPHTHALMIC |
Start Marketing Date | 20080425 |
Marketing Category Name | ANDA |
Labeler Name | Bausch & Lomb Incorporated |
Substance Name | BACITRACIN ZINC; POLYMYXIN B SULFATE |
Strength Number | 500; 10000 |
Strength Unit | 1/g; 1/g |
Pharmaceutical Classes | Decreased Cell Wall Synthesis & Repair [PE],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |